Benjamin J. Zeskind Immuneering Corp (IMRX) insider trading activity
Benjamin J. Zeskind is PRESIDENT AND CEO of Immuneering Corp. Currently has a direct ownership of 2.28 Million shares of IMRX, which is worth approximately $4.27 Million. The most recent transaction as insider was on Mar 19, 2024, when has been sold 20,000 shares (Class A Common Stock) at a price of $2.77 per share, resulting in proceeds of $55,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.28M
0%
3M change
0.88%
12M change
Total Value Held
$4.27 Million
Benjamin J. Zeskind Transaction History
BJZ
Benjamin J. Zeskind
PRESIDENT AND CEO
Cambridge, MA